HRP20130171T1 - Farmaceutska formulacija za lijeäśenje gornjeg probavnog sustava - Google Patents
Farmaceutska formulacija za lijeäśenje gornjeg probavnog sustava Download PDFInfo
- Publication number
- HRP20130171T1 HRP20130171T1 HRP20130171AT HRP20130171T HRP20130171T1 HR P20130171 T1 HRP20130171 T1 HR P20130171T1 HR P20130171A T HRP20130171A T HR P20130171AT HR P20130171 T HRP20130171 T HR P20130171T HR P20130171 T1 HRP20130171 T1 HR P20130171T1
- Authority
- HR
- Croatia
- Prior art keywords
- effervescent tablet
- intended
- accordance
- digestive system
- upper digestive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (10)
1. Pjenušava tableta koja sadrži budezonid, naznačena time što je namijenjena formuliranju otopine za ispiranje usta koju se može primijeniti oralno, namijenjenoj upotrebi u liječenju upalnih promjena gornjeg probavnog sustava.
2. Pjenušava tableta namijenjena upotrebi u skladu s patentni zahtjev 1, naznačena time što sadrži 0,1 do 10 mg budezonida po pjenušavoj tableti.
3. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 ili 2, naznačena time što sadrži polivinilpirolidon u koncentraciji od 0,5 do 10%, težinski, na osnovu težine pjenušave tablete.
4. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačena time što sadrži natrijev dokusat u koncentraciji od 0,1‰ do 5,0‰, težinski, na osnovu pjenušave tablete.
5. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačena time što sadrži pjenušavu smjesu koja sadrži farmaceutski prihvatljivu kiselinu u čvrstom obliku, te spoj koji sadrži karbonat i/ili hidrogenkarbonat.
6. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačena time što sadrži sredstvo koje uzrokuje učinak hlađenja u ustima u koncentraciji od 0,1 do 1,0%, težinski, u odnosu na gotovu pjenušavu tabletu.
7. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačena time što je upalna promjena gornjeg probavnog sustava lokalizirana na području usne šupljine i/ili ždrijela.
8. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 6, naznačena time što su upalne promjene gornjeg probavnog sustava neinfektivne upale.
9. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 6, naznačena time što je upalna promjena gornjeg probavnog sustava uzrokovana kemoterapijom.
10. Pjenušava tableta namijenjena upotrebi u skladu s bilo kojim od patentnih zahtjeva 1 do 6, naznačena time što je upalna promjena gornjeg probavnog sustava uzrokovana mukozitisom, autoimunom bolešću usne šupljine, Crohnovom bolešću u gornjem probavnom sustavu ili eozinofilnim ezofagitisom.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08013091A EP2151235B1 (de) | 2008-07-21 | 2008-07-21 | Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes |
| PCT/EP2009/058320 WO2010009961A1 (de) | 2008-07-21 | 2009-07-02 | Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20130171T1 true HRP20130171T1 (hr) | 2013-03-31 |
Family
ID=39951664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20130171AT HRP20130171T1 (hr) | 2008-07-21 | 2009-07-02 | Farmaceutska formulacija za lijeäśenje gornjeg probavnog sustava |
| HR20110208T HRP20110208T1 (hr) | 2008-07-21 | 2011-03-23 | Farmaceutska formulacija za liječenje gornjeg probavnog sustava |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110208T HRP20110208T1 (hr) | 2008-07-21 | 2011-03-23 | Farmaceutska formulacija za liječenje gornjeg probavnog sustava |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8580300B2 (hr) |
| EP (2) | EP2151235B1 (hr) |
| JP (2) | JP5616889B2 (hr) |
| CN (1) | CN102159196B (hr) |
| AT (1) | ATE498396T1 (hr) |
| AU (1) | AU2009273361B2 (hr) |
| CA (1) | CA2731312C (hr) |
| CY (2) | CY1111878T1 (hr) |
| DE (1) | DE502008002621D1 (hr) |
| DK (2) | DK2151235T3 (hr) |
| EA (1) | EA018465B1 (hr) |
| ES (2) | ES2358158T3 (hr) |
| HR (2) | HRP20130171T1 (hr) |
| IL (1) | IL210779A (hr) |
| ME (2) | ME01256B (hr) |
| NZ (1) | NZ590593A (hr) |
| PL (2) | PL2151235T3 (hr) |
| PT (2) | PT2151235E (hr) |
| RS (2) | RS51649B (hr) |
| SI (2) | SI2151235T1 (hr) |
| UA (1) | UA100759C2 (hr) |
| WO (1) | WO2010009961A1 (hr) |
| ZA (1) | ZA201100283B (hr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8895064B2 (en) * | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| CA2377301C (en) | 1999-06-14 | 2009-05-12 | Cosmo S.P.A. | Controlled release and taste masking oral pharmaceutical compositions |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| ES2358158T3 (es) * | 2008-07-21 | 2011-05-06 | Dr. Falk Pharma Gmbh | Formulación farmacéutica para el tratamiento del tracto digestivo superior. |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| MX364947B (es) | 2009-10-01 | 2019-05-15 | Adare Pharmaceuticals Inc | Composiciones de corticosteroides administradas oralmente. |
| US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
| PT2886108T (pt) * | 2013-12-23 | 2019-04-01 | Dr Falk Pharma Gmbh | Formulação farmacêutica otimizada para o tratamento de alterações inflamatórias do esófago |
| TWI728172B (zh) | 2016-08-18 | 2021-05-21 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
| FI3870226T3 (fi) | 2018-10-24 | 2023-09-15 | Ferring Bv | Mukoadhesiivisia kortikosteroidien farmaseuttisia koostumuksia |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4332394A1 (de) | 1993-09-23 | 1995-03-30 | Falk Pharma Gmbh | Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung |
| US5639475A (en) * | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
| US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| US5807577A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| US5807578A (en) * | 1995-11-22 | 1998-09-15 | Lab Pharmaceutical Research International Inc. | Fast-melt tablet and method of making same |
| GB9611364D0 (en) * | 1996-05-31 | 1996-08-07 | Smithkline Beecham Plc | Composition |
| US6350470B1 (en) * | 1998-04-29 | 2002-02-26 | Cima Labs Inc. | Effervescent drug delivery system for oral administration |
| JP3818789B2 (ja) * | 1999-02-18 | 2006-09-06 | 三菱化学フーズ株式会社 | 易崩壊性錠剤 |
| JP4038772B2 (ja) | 2001-07-11 | 2008-01-30 | 敏朗 関根 | 光合成微生物の培養方法と装置 |
| EA200400455A1 (ru) * | 2001-09-25 | 2004-10-28 | Ранбакси Лабораторис Лимитед | Способ приготовления быстрорастворимой дозировочной формы |
| WO2003043518A2 (en) * | 2001-11-20 | 2003-05-30 | Dmi Biosciences, Inc. | Methods and products for oral care |
| WO2003080023A2 (en) * | 2002-03-20 | 2003-10-02 | Elan Pharma International Limited | Fast dissolving dosage forms having reduced friability |
| SE0401031D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
| US20060013873A1 (en) * | 2004-07-16 | 2006-01-19 | Chih-Chiang Yang | Bioadhesive dosage form of steroids |
| US20070071817A1 (en) * | 2005-09-26 | 2007-03-29 | Phyzz, Inc. | Effervescent oral care compositions and method of use |
| JP2009526858A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | コルチコステロイド溶液を製造する方法 |
| HRP20161388T1 (hr) * | 2007-06-22 | 2016-12-02 | Dompé Farmaceutici S.P.A. | Šumeće tablete namijenjene upotrebi u inhalatoru |
| EP2205213A2 (en) * | 2007-10-01 | 2010-07-14 | Laboratorios Lesvi, S.L. | Orodispersible tablets |
| ES2358158T3 (es) * | 2008-07-21 | 2011-05-06 | Dr. Falk Pharma Gmbh | Formulación farmacéutica para el tratamiento del tracto digestivo superior. |
| WO2010144865A2 (en) * | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
-
2008
- 2008-07-21 ES ES08013091T patent/ES2358158T3/es active Active
- 2008-07-21 ME MEP-2011-46A patent/ME01256B/me unknown
- 2008-07-21 DK DK08013091.7T patent/DK2151235T3/da active
- 2008-07-21 PT PT08013091T patent/PT2151235E/pt unknown
- 2008-07-21 PL PL08013091T patent/PL2151235T3/pl unknown
- 2008-07-21 SI SI200830187T patent/SI2151235T1/sl unknown
- 2008-07-21 RS RS20110100A patent/RS51649B/sr unknown
- 2008-07-21 EP EP08013091A patent/EP2151235B1/de active Active
- 2008-07-21 AT AT08013091T patent/ATE498396T1/de active
- 2008-07-21 DE DE502008002621T patent/DE502008002621D1/de active Active
-
2009
- 2009-02-07 UA UAA201101686A patent/UA100759C2/uk unknown
- 2009-07-02 PL PL09800023T patent/PL2306988T3/pl unknown
- 2009-07-02 EP EP09800023A patent/EP2306988B1/de not_active Revoked
- 2009-07-02 DK DK09800023.5T patent/DK2306988T3/da active
- 2009-07-02 PT PT98000235T patent/PT2306988E/pt unknown
- 2009-07-02 ES ES09800023T patent/ES2399321T3/es active Active
- 2009-07-02 CA CA2731312A patent/CA2731312C/en not_active Expired - Fee Related
- 2009-07-02 AU AU2009273361A patent/AU2009273361B2/en not_active Ceased
- 2009-07-02 JP JP2011519101A patent/JP5616889B2/ja not_active Expired - Fee Related
- 2009-07-02 RS RS20130071A patent/RS52662B/sr unknown
- 2009-07-02 CN CN2009801358800A patent/CN102159196B/zh not_active Expired - Fee Related
- 2009-07-02 SI SI200930502T patent/SI2306988T1/sl unknown
- 2009-07-02 ME MEP-2013-22A patent/ME01494B/me unknown
- 2009-07-02 NZ NZ590593A patent/NZ590593A/en unknown
- 2009-07-02 US US13/054,844 patent/US8580300B2/en not_active Expired - Fee Related
- 2009-07-02 EA EA201100229A patent/EA018465B1/ru not_active IP Right Cessation
- 2009-07-02 WO PCT/EP2009/058320 patent/WO2010009961A1/de not_active Ceased
- 2009-07-02 HR HRP20130171AT patent/HRP20130171T1/hr unknown
-
2011
- 2011-01-11 ZA ZA2011/00283A patent/ZA201100283B/en unknown
- 2011-01-20 IL IL210779A patent/IL210779A/en active IP Right Grant
- 2011-03-11 CY CY20111100274T patent/CY1111878T1/el unknown
- 2011-03-23 HR HR20110208T patent/HRP20110208T1/hr unknown
-
2013
- 2013-02-26 CY CY20131100174T patent/CY1113719T1/el unknown
- 2013-10-23 US US14/061,578 patent/US20140079646A1/en not_active Abandoned
-
2014
- 2014-07-30 JP JP2014155149A patent/JP6209495B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20130171T1 (hr) | Farmaceutska formulacija za lijeäśenje gornjeg probavnog sustava | |
| ES2314049T3 (es) | Formulaciones liquidas para la prevencion y el tratamiento de enfermedades y trastornos de la mucosa. | |
| EP2364144A4 (en) | PHARMACEUTICAL FORM FOR ADMINISTRATION THROUGH THE MOUTH | |
| ES2539310T3 (es) | Composiciones bucosolubles que contienen al menos una sal de S-adenosilmetionina (SAMe) | |
| MX2008000087A (es) | Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5. | |
| BRPI0414311A (pt) | formas de dosagem de liberação controlada | |
| ES2606342T3 (es) | Composiciones para el cuidado bucal de sal estannosa y tripoli-fosfato de sodio y métodos | |
| PE20050175A1 (es) | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad | |
| UA108360C2 (uk) | Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині | |
| JP2014221827A5 (hr) | ||
| AR042246A1 (es) | Composiciones farmaceuticas que comprenden un compuesto farmacologico basico o acido, un surfactante y un acido o base hidrosoluble fisiologicamente tolerable respectivamente | |
| ES2262999T3 (es) | Composicion farmaceutica orodispersable de agomelatina. | |
| JP2007523091A5 (hr) | ||
| BR112013006597A2 (pt) | tablete para desintegração oral em múltiplas camadas, e a fabricação do mesmo | |
| JP2010047612A5 (hr) | ||
| ES2572157T3 (es) | Composiciones en forma de partículas para la administración de fármacos poco solubles | |
| MX2009003030A (es) | Forma galenita para la administracion por via transmucosa de principios activos. | |
| JP2014500246A5 (hr) | ||
| DE602005025755D1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
| AR061790A1 (es) | Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento | |
| PE20081106A1 (es) | Comprimidos pediatricos de capecitabina | |
| ES2716990T3 (es) | Formulación farmacéutica optimizada para el tratamiento de cambios inflamatorios del esófago | |
| JP2016503803A5 (hr) | ||
| HRP20230762T1 (hr) | Nalmefen za smanjenje konzumacije alkohola u specifičnim ciljnim populacijama | |
| ES2652266T3 (es) | Composición sólida de dosificación oral de ibuprofeno que comprende un copolímero de ácido metacrílico |